8:26 AM
Leo Group India
| ||
| Teva Pharmaceuticals: 2013 Revised Guidance Could Signal A Buying ... Seeking Alpha Teva Pharmaceuticals (TEVA) was hit hard in the pre-market trading Friday morning. The company, under new leadership, announced that revenues and earnings could come in below analyst expectations for 2013, and the sell-off was rapid and hard. Shares ... See all stories on this topic » | ||
| 3 Pharmaceuticals With Promising Growth Catalysts To Consider Now Seeking Alpha In this article, I will focus on three pharmaceutical companies that are seeing new growth catalysts which could push their share prices higher in the coming weeks and months. PROLOR Biotech (PBTH) engages in the development of proprietary versions of ... See all stories on this topic » | ||
| SciClone Pharmaceuticals reports net loss for Q3, revises guidance for 2012 Equities.com Dec 03, 2012 (Datamonitor via COMTEX) -- SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, has reported that net loss for the third quarter ended September 30, 2012 was $13.54 million, or $0.24 loss per diluted share, compared to a ... See all stories on this topic » | ||
| Merck Serono and Neopharma announce first pharmaceutical production ... AME Info Under the patronage of H.E. Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Higher Education and Scientific Research and Chairman of Neopharma, global pharmaceutical, Merck Serono, a division of Merck KGaA, Germany, and a local manufacturer, ... See all stories on this topic » | ||
| Questcor Pharmaceuticals Dip Offers Opportunity In Front Of Acthar Script Data Seeking Alpha Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business ... See all stories on this topic » | ||
| Practice Safe Rx Huffington Post While Americans never have enjoyed access to so many pharmaceutical products with such life-sustaining and lifesaving properties, these drugs also have proven to be expensive — prohibitively so for many — and, as I've written in this blog before ... See all stories on this topic » | ||
| Analyst Downgrades: Intel, Teva Pharmaceutical, and QLogic Schaeffers Research (blog) Analysts are weighing in today on semiconductor behemoth Intel Corporation (NASDAQ:INTC - 19.57), drug maker Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA - 40.35), and tech issue QLogic Corporation (NASDAQ:QLGC - 9.48). Here's a quick ... See all stories on this topic » | ||
| Bayer Healthcare Pharmaceuticals' Leadership Summit Features Keynote by ... Equities.com Jim Murphy, founder of the global management training firm, Afterburner, was featured as the guest speaker at Bayer Healthcare's annual leadership meeting in Portugal this month. The concept behind Flawless Execution® combines combat-derived strategy ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment